• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconVaccine

Vaccine

Page 9 of 13
Global stocks tumble as the Fed’s ‘near-zero’ rates pledge leaves investors unsatisfied
Newsletters
Global stocks tumble as the Fed’s ‘near-zero’ rates pledge leaves investors unsatisfied
By Bernhard WarnerSeptember 17, 2020
U.S. outlines sweeping plan to provide free COVID-19 vaccines
Health
U.S. outlines sweeping plan to provide free COVID-19 vaccines
By The Associated PressSeptember 16, 2020
The tech-stock bulls are back
Newsletters
The tech-stock bulls are back
By Bernhard WarnerSeptember 16, 2020
China’s controversial emergency-use program for COVID vaccines is going global
Health
China’s controversial emergency-use program for COVID vaccines is going global
By Grady McGregorSeptember 16, 2020
Is M&A back? Investors hope so, and that’s lifting global stocks
Newsletters
Is M&A back? Investors hope so, and that’s lifting global stocks
By Bernhard WarnerSeptember 15, 2020
A flurry of M&A deals lifts global stocks. Yes, even tech stocks
Newsletters
A flurry of M&A deals lifts global stocks. Yes, even tech stocks
By Bernhard WarnerSeptember 14, 2020
AstraZeneca’s COVID-19 vaccine is back on track after getting the green light to resume trials in the U.K.
Health
AstraZeneca’s COVID-19 vaccine is back on track after getting the green light to resume trials in the U.K.
By Stephanie Baker and BloombergSeptember 13, 2020
Census worker Anna Arroyo takes calls about the census. At City Hall in Reading, PA Tuesday afternoon September 1, 2020 where bilingual census workers were taking calls from the public about providing their information for the 2020 census.
Newsletters
The future of the call center
By David Meyer and Alan MurraySeptember 11, 2020
When will a COVID vaccine be ready? The fourth quarter or early 2021, top Chinese vaccine executive says
Conferences
When will a COVID vaccine be ready? The fourth quarter or early 2021, top Chinese vaccine executive says
By Grady McGregorSeptember 11, 2020
Close-up of someone receiving a vaccination.
Health
COVID-19 vaccine still on track for later this year despite trial pause, AstraZeneca CEO says
By Jeremy KahnSeptember 10, 2020
CEO of Pfizer Inc. Albert Bourla, DVM, Ph.D. attends 2019 Forbes Healthcare Summit at the Jazz at Lincoln Center on December 05, 2019 in New York City.
Newsletters
Pfizer’s Albert Bourla: Vaccine efforts are improving Big Pharma’s reputation
By David Meyer and Alan MurraySeptember 10, 2020
Global markets dip as investors again sour on tech stocks
Newsletters
Global markets dip as investors again sour on tech stocks
By Bernhard WarnerSeptember 10, 2020
Scientists see an upside to AstraZeneca halting its COVID-19 vaccine trial
Scientists see an upside to AstraZeneca halting its COVID-19 vaccine trial
By Grady McGregorSeptember 9, 2020
Global stocks climb—and futures jump—after Tuesday’s sell-off
Newsletters
Global stocks climb—and futures jump—after Tuesday’s sell-off
By Bernhard WarnerSeptember 9, 2020
Why last week’s great tech sell-off should make investors wary
Newsletters
Why last week’s great tech sell-off should make investors wary
By Bernhard WarnerSeptember 8, 2020
1...
  • 7
  • 8
  • 9
  • 10
  • 11
...13
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimisticplaceholder alt text
By Jason MaJuly 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.